Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells

Rosa Sirianni, Adele Chimento, Arianna De Luca, Fabiana Zolea, Amalia Carpino, Vittoria Rago, Marcello Maggiolini, Sebastiano Andò, Vincenzo Pezzi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Our recent studies have revealed that estrogens stimulate an autocrine mechanism determining Leydig tumor cell proliferation. Estrogen overproduction is due to an elevated steroidogenic factor-1 (SF-1) expression and cAMP-response element-binding protein (CREB) phosphorylation, both inducing aromatase overexpression. Although we have shown that increased SF-1 expression depends mainly on higher local insulin-like growth factor I production, the mechanisms and factors determining increased CREB activation in Leydig tumor cells are not completely understood. In this study, we investigated the role of cyclooxygenase-2 (COX-2) in CREB dependent- aromatase expression in Leydig tumor cells. We found that COX-2 is expressed in rat and human Leydigiomas as well as in the rat Leydig tumor cell line R2C, but not in normal testis. Our data indicate that in R2C cells the COX-2-derived prostaglandin E2 (PGE2) binds the PGE2 receptor EP4 and activates protein kinase A (PKA) and ultimately CREB. Inhibitors for COX-2 (NS398), EP4 (AH23848), and PKA (H89) decreased aromatase expression and activity as a consequence of a decreased phosphorylated CREB recruitment to the PII promoter of the aromatase gene. The COX-2/PGE2/PKA pathway also seems to be involved in aromatase post-translational activation, an observation that requires further studies. The reduction in aromatase activity was responsible for a drop in estrogen production and subsequent reduction in cyclin E expression resulting in a decrease in tumor Leydig cell proliferation. Furthermore, COX-2 silencing caused a significant decrease in CREB phosphorylation, aromatase expression, and R2C cell proliferation. These novel findings clarify the mechanisms involved in the growth of Leydig cell tumors and should be taken into account in determining new therapeutic approaches.

Original languageEnglish (US)
Pages (from-to)28905-28916
Number of pages12
JournalJournal of Biological Chemistry
Volume284
Issue number42
DOIs
StatePublished - Oct 16 2009

Fingerprint

Leydig Cell Tumor
Aromatase
Cyclic AMP Response Element-Binding Protein
Cyclooxygenase 2
Tumors
Down-Regulation
Cells
Cell proliferation
Cyclic AMP-Dependent Protein Kinases
Steroidogenic Factor 1
Dinoprostone
Estrogens
Phosphorylation
Cell Proliferation
Rats
Chemical activation
Prostaglandin Receptors
Cyclin E
Cyclooxygenase 2 Inhibitors
Tumor Cell Line

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Sirianni, R., Chimento, A., De Luca, A., Zolea, F., Carpino, A., Rago, V., ... Pezzi, V. (2009). Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells. Journal of Biological Chemistry, 284(42), 28905-28916. https://doi.org/10.1074/jbc.M109.041020

Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells. / Sirianni, Rosa; Chimento, Adele; De Luca, Arianna; Zolea, Fabiana; Carpino, Amalia; Rago, Vittoria; Maggiolini, Marcello; Andò, Sebastiano; Pezzi, Vincenzo.

In: Journal of Biological Chemistry, Vol. 284, No. 42, 16.10.2009, p. 28905-28916.

Research output: Contribution to journalArticle

Sirianni, R, Chimento, A, De Luca, A, Zolea, F, Carpino, A, Rago, V, Maggiolini, M, Andò, S & Pezzi, V 2009, 'Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells', Journal of Biological Chemistry, vol. 284, no. 42, pp. 28905-28916. https://doi.org/10.1074/jbc.M109.041020
Sirianni, Rosa ; Chimento, Adele ; De Luca, Arianna ; Zolea, Fabiana ; Carpino, Amalia ; Rago, Vittoria ; Maggiolini, Marcello ; Andò, Sebastiano ; Pezzi, Vincenzo. / Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 42. pp. 28905-28916.
@article{19230977691b44539814ee712d232094,
title = "Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells",
abstract = "Our recent studies have revealed that estrogens stimulate an autocrine mechanism determining Leydig tumor cell proliferation. Estrogen overproduction is due to an elevated steroidogenic factor-1 (SF-1) expression and cAMP-response element-binding protein (CREB) phosphorylation, both inducing aromatase overexpression. Although we have shown that increased SF-1 expression depends mainly on higher local insulin-like growth factor I production, the mechanisms and factors determining increased CREB activation in Leydig tumor cells are not completely understood. In this study, we investigated the role of cyclooxygenase-2 (COX-2) in CREB dependent- aromatase expression in Leydig tumor cells. We found that COX-2 is expressed in rat and human Leydigiomas as well as in the rat Leydig tumor cell line R2C, but not in normal testis. Our data indicate that in R2C cells the COX-2-derived prostaglandin E2 (PGE2) binds the PGE2 receptor EP4 and activates protein kinase A (PKA) and ultimately CREB. Inhibitors for COX-2 (NS398), EP4 (AH23848), and PKA (H89) decreased aromatase expression and activity as a consequence of a decreased phosphorylated CREB recruitment to the PII promoter of the aromatase gene. The COX-2/PGE2/PKA pathway also seems to be involved in aromatase post-translational activation, an observation that requires further studies. The reduction in aromatase activity was responsible for a drop in estrogen production and subsequent reduction in cyclin E expression resulting in a decrease in tumor Leydig cell proliferation. Furthermore, COX-2 silencing caused a significant decrease in CREB phosphorylation, aromatase expression, and R2C cell proliferation. These novel findings clarify the mechanisms involved in the growth of Leydig cell tumors and should be taken into account in determining new therapeutic approaches.",
author = "Rosa Sirianni and Adele Chimento and {De Luca}, Arianna and Fabiana Zolea and Amalia Carpino and Vittoria Rago and Marcello Maggiolini and Sebastiano And{\`o} and Vincenzo Pezzi",
year = "2009",
month = "10",
day = "16",
doi = "10.1074/jbc.M109.041020",
language = "English (US)",
volume = "284",
pages = "28905--28916",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "42",

}

TY - JOUR

T1 - Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells

AU - Sirianni, Rosa

AU - Chimento, Adele

AU - De Luca, Arianna

AU - Zolea, Fabiana

AU - Carpino, Amalia

AU - Rago, Vittoria

AU - Maggiolini, Marcello

AU - Andò, Sebastiano

AU - Pezzi, Vincenzo

PY - 2009/10/16

Y1 - 2009/10/16

N2 - Our recent studies have revealed that estrogens stimulate an autocrine mechanism determining Leydig tumor cell proliferation. Estrogen overproduction is due to an elevated steroidogenic factor-1 (SF-1) expression and cAMP-response element-binding protein (CREB) phosphorylation, both inducing aromatase overexpression. Although we have shown that increased SF-1 expression depends mainly on higher local insulin-like growth factor I production, the mechanisms and factors determining increased CREB activation in Leydig tumor cells are not completely understood. In this study, we investigated the role of cyclooxygenase-2 (COX-2) in CREB dependent- aromatase expression in Leydig tumor cells. We found that COX-2 is expressed in rat and human Leydigiomas as well as in the rat Leydig tumor cell line R2C, but not in normal testis. Our data indicate that in R2C cells the COX-2-derived prostaglandin E2 (PGE2) binds the PGE2 receptor EP4 and activates protein kinase A (PKA) and ultimately CREB. Inhibitors for COX-2 (NS398), EP4 (AH23848), and PKA (H89) decreased aromatase expression and activity as a consequence of a decreased phosphorylated CREB recruitment to the PII promoter of the aromatase gene. The COX-2/PGE2/PKA pathway also seems to be involved in aromatase post-translational activation, an observation that requires further studies. The reduction in aromatase activity was responsible for a drop in estrogen production and subsequent reduction in cyclin E expression resulting in a decrease in tumor Leydig cell proliferation. Furthermore, COX-2 silencing caused a significant decrease in CREB phosphorylation, aromatase expression, and R2C cell proliferation. These novel findings clarify the mechanisms involved in the growth of Leydig cell tumors and should be taken into account in determining new therapeutic approaches.

AB - Our recent studies have revealed that estrogens stimulate an autocrine mechanism determining Leydig tumor cell proliferation. Estrogen overproduction is due to an elevated steroidogenic factor-1 (SF-1) expression and cAMP-response element-binding protein (CREB) phosphorylation, both inducing aromatase overexpression. Although we have shown that increased SF-1 expression depends mainly on higher local insulin-like growth factor I production, the mechanisms and factors determining increased CREB activation in Leydig tumor cells are not completely understood. In this study, we investigated the role of cyclooxygenase-2 (COX-2) in CREB dependent- aromatase expression in Leydig tumor cells. We found that COX-2 is expressed in rat and human Leydigiomas as well as in the rat Leydig tumor cell line R2C, but not in normal testis. Our data indicate that in R2C cells the COX-2-derived prostaglandin E2 (PGE2) binds the PGE2 receptor EP4 and activates protein kinase A (PKA) and ultimately CREB. Inhibitors for COX-2 (NS398), EP4 (AH23848), and PKA (H89) decreased aromatase expression and activity as a consequence of a decreased phosphorylated CREB recruitment to the PII promoter of the aromatase gene. The COX-2/PGE2/PKA pathway also seems to be involved in aromatase post-translational activation, an observation that requires further studies. The reduction in aromatase activity was responsible for a drop in estrogen production and subsequent reduction in cyclin E expression resulting in a decrease in tumor Leydig cell proliferation. Furthermore, COX-2 silencing caused a significant decrease in CREB phosphorylation, aromatase expression, and R2C cell proliferation. These novel findings clarify the mechanisms involved in the growth of Leydig cell tumors and should be taken into account in determining new therapeutic approaches.

UR - http://www.scopus.com/inward/record.url?scp=70350365401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350365401&partnerID=8YFLogxK

U2 - 10.1074/jbc.M109.041020

DO - 10.1074/jbc.M109.041020

M3 - Article

VL - 284

SP - 28905

EP - 28916

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 42

ER -